Tossing Bombs: Third Party Submissions in Pending U.S. Patent Applications

The America Invents Act brings to the USPTO a relatively simple and inexpensive way to influence the early prosecution of competitors’ patent applications. Third Party Submissions allow anybody to provide Examiners with prior art and explain why it matters. Read More...
Comments

Prometheus and Myriad: What can you Patent?

The Prometheus and Myriad cases are changing the landscape for biotechnology patents. Patent-eligible subject matter is in flux. Can you still claim a method for diagnosing a disease, identifying a drug candidate, or tailoring a therapeutic regimen to the needs of individual patients? What is the status of isolated DNA and protein claims? Read on for a discussion patent-eligible subject matter in the life sciences. Read More...
Comments

Private PAIR on a Mac

Yes, I’m a Macintosh geek. If you are having problems authenticating your Private PAIR session on your Mac, I have a fix that is a lot easier then the USPTO’s fix (downgrading Java from version 7 to version 6). Read More...
Comments

Unitary European Patent

Unitary European Patent to relieve requirement for validation of EPO patents in individual European countries. Unitary Patent Court will try patent infringement cases with (essentially) Europe-wide jurisdiction. This will mean great savings to patent applicants and patentees. Read More...
Comments